Coccidioidomycosis during pregnancy: A review and recommendations for management

Robert S. Bercovitch, Antonino Catanzaro, Brian S. Schwartz, Demosthenes Pappagianis, Watts D.Heather Watts, Neil M. Ampel

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.

Original languageEnglish (US)
Pages (from-to)363-368
Number of pages6
JournalClinical Infectious Diseases
Volume53
Issue number4
DOIs
StatePublished - Aug 15 2011

Fingerprint

Coccidioidomycosis
Pregnancy
Azoles
Antifungal Agents
Cohort Studies
Infection

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Bercovitch, R. S., Catanzaro, A., Schwartz, B. S., Pappagianis, D., D.Heather Watts, W., & Ampel, N. M. (2011). Coccidioidomycosis during pregnancy: A review and recommendations for management. Clinical Infectious Diseases, 53(4), 363-368. https://doi.org/10.1093/cid/cir410

Coccidioidomycosis during pregnancy : A review and recommendations for management. / Bercovitch, Robert S.; Catanzaro, Antonino; Schwartz, Brian S.; Pappagianis, Demosthenes; D.Heather Watts, Watts; Ampel, Neil M.

In: Clinical Infectious Diseases, Vol. 53, No. 4, 15.08.2011, p. 363-368.

Research output: Contribution to journalArticle

Bercovitch, RS, Catanzaro, A, Schwartz, BS, Pappagianis, D, D.Heather Watts, W & Ampel, NM 2011, 'Coccidioidomycosis during pregnancy: A review and recommendations for management', Clinical Infectious Diseases, vol. 53, no. 4, pp. 363-368. https://doi.org/10.1093/cid/cir410
Bercovitch, Robert S. ; Catanzaro, Antonino ; Schwartz, Brian S. ; Pappagianis, Demosthenes ; D.Heather Watts, Watts ; Ampel, Neil M. / Coccidioidomycosis during pregnancy : A review and recommendations for management. In: Clinical Infectious Diseases. 2011 ; Vol. 53, No. 4. pp. 363-368.
@article{c33ba025650f4bba9eca497967cc00eb,
title = "Coccidioidomycosis during pregnancy: A review and recommendations for management",
abstract = "Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.",
author = "Bercovitch, {Robert S.} and Antonino Catanzaro and Schwartz, {Brian S.} and Demosthenes Pappagianis and {D.Heather Watts}, Watts and Ampel, {Neil M.}",
year = "2011",
month = "8",
day = "15",
doi = "10.1093/cid/cir410",
language = "English (US)",
volume = "53",
pages = "363--368",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Coccidioidomycosis during pregnancy

T2 - A review and recommendations for management

AU - Bercovitch, Robert S.

AU - Catanzaro, Antonino

AU - Schwartz, Brian S.

AU - Pappagianis, Demosthenes

AU - D.Heather Watts, Watts

AU - Ampel, Neil M.

PY - 2011/8/15

Y1 - 2011/8/15

N2 - Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.

AB - Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=79961221685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961221685&partnerID=8YFLogxK

U2 - 10.1093/cid/cir410

DO - 10.1093/cid/cir410

M3 - Article

C2 - 21810749

AN - SCOPUS:79961221685

VL - 53

SP - 363

EP - 368

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 4

ER -